Answers are grounded in this paper and cite their sources.
Novel synthesis method expands peptide structures in solid-phase peptide synthesis, indicating greater efficiency and product purity.
A significant advancement in Merrifield’s classic solid-phase peptide synthesis (SPPS) that greatly expands the scope of accessible peptide structures is reported here. Building upon the one-bead, one-compound concept, this approach enables the simultaneous synthesis of multiple peptides on a single bead, followed by a novel solid-phase interchain assembly reaction to produce the final peptide product. This method successfully generates diverse peptide architectures, including linear, cyclic, and bi-cyclic structures—ranging from minimal cyclic dipeptides to small proteins—many of which are inaccessible through conventional SPPS. This new protocol demonstrates superior efficiency in both time and product purity compared to traditional methods. Crucially, it eliminates the need for solution-phase fragment condensation, a common but cumbersome step commonly used in synthesising therapeutic peptides (30–60 amino acids). Beyond improving classic SPPS methodologies, this breakthrough unlocks entirely new families of peptide structures, including highly constrained peptides previously deemed unsynthesisable.
No takes yet. Share an insight, caveat, or question.
Musaimi et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: